TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Global Pharma Consulting (GPC) AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
543
|
414
|
631 |
| Financial expenses |
7
|
1
|
0 |
| Earnings before taxes |
-7
|
-237
|
-91 |
| EBITDA |
-1
|
-236
|
-91 |
| Total assets |
383
|
322
|
534 |
| Current assets |
383
|
322
|
534 |
| Current liabilities |
351
|
284
|
438 |
| Equity capital |
32
|
38
|
96 |
| - share capital |
34
|
33
|
36 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
8.4%
|
11.8%
|
18.0% |
| Turnover per employee |
543
|
414
|
631 |
| Profit as a percentage of turnover |
-1.3%
|
-57.2%
|
-14.4% |
| Return on assets (ROA) |
0%
|
-73.3%
|
-17.0% |
| Current ratio |
109.1%
|
113.4%
|
121.9% |
| Return on equity (ROE) |
-21.9%
|
-623.7%
|
-94.8% |
| Change turnover |
127
|
-166
|
-812 |
| Change turnover % |
30%
|
-29%
|
-56% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.